Want to see JP:4519 full AI Analyst Report?
Chugai Pharmaceutical Co (4519) Financial Statements
Chugai Pharmaceutical Co Financial Overview
Chugai Pharmaceutical Co's market cap is currently $11.23T. The company's EPS TTM is $306.08; its P/E ratio is 22.29; and it has a dividend yield of 3.12%. Chugai Pharmaceutical Co is scheduled to report earnings on February 4, 2027, and the estimated EPS forecast is $77.88. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.26T | $ 1.17T | $ 1.11T | $ 1.26T | $ 999.76B |
| Gross Profit | $ 894.25B | $ 830.75B | $ 693.01B | $ 783.06B | $ 660.27B |
| Operating Income | $ 590.19B | $ 543.91B | $ 415.67B | $ 533.94B | $ 433.74B |
| EBITDA | $ 631.37B | $ 574.80B | $ 475.64B | $ 562.66B | $ 450.30B |
| Net Income | $ 434.01B | $ 387.32B | $ 325.47B | $ 374.43B | $ 303.00B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 979.70B | $ 996.35B | $ 738.98B | $ 503.11B | $ 471.97B |
| Total Assets | $ 2.47T | $ 2.21T | $ 1.93T | $ 1.87T | $ 1.54T |
| Total Debt | $ 0.00 | $ 10.90B | $ 13.46B | $ 14.11B | $ 16.04B |
| Net Debt | $ -426.60B | $ -529.30B | $ -445.22B | $ -208.06B | $ -251.71B |
| Total Liabilities | $ 442.86B | $ 306.87B | $ 306.97B | $ 445.37B | $ 350.68B |
| Stockholders' Equity | $ 2.03T | $ 1.90T | $ 1.63T | $ 1.42T | $ 1.19T |
| Cash Flow | |||||
| Free Cash Flow | $ 313.18B | $ 396.68B | $ 335.67B | $ 172.87B | $ 206.76B |
| Operating Cash Flow | $ 389.45B | $ 447.60B | $ 409.93B | $ 244.11B | $ 279.63B |
| Investing Cash Flow | $ -204.87B | $ -227.37B | $ -37.29B | $ -145.99B | $ -118.93B |
| Financing Cash Flow | $ -307.46B | $ -141.01B | $ -139.33B | $ -145.64B | $ -107.41B |
Currency in JPY